IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 48 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $19,000 | +46.2% | 49,876 | +70.9% | 0.00% | +100.0% |
Q2 2022 | $13,000 | -43.5% | 29,179 | -37.1% | 0.00% | -50.0% |
Q1 2022 | $23,000 | -94.1% | 46,368 | -85.7% | 0.00% | -94.7% |
Q2 2021 | $390,000 | +104.2% | 325,330 | +120.9% | 0.04% | +171.4% |
Q1 2021 | $191,000 | +377.5% | 147,252 | +568.2% | 0.01% | +250.0% |
Q4 2019 | $40,000 | +21.2% | 22,038 | +84.8% | 0.00% | +100.0% |
Q4 2018 | $33,000 | – | 11,923 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 4,839,895 | $12,342,000 | 0.08% |
GSA CAPITAL PARTNERS LLP | 65,448 | $167,000 | 0.02% |
MYCIO WEALTH PARTNERS, LLC | 55,815 | $142,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 187,445 | $478,000 | 0.01% |
ZACKS INVESTMENT MANAGEMENT | 168,781 | $430,000 | 0.01% |
Candriam S.C.A. | 290,000 | $740,000 | 0.01% |
Assenagon Asset Management S.A. | 355,728 | $907,000 | 0.01% |
Palo Alto Investors LP | 77,044 | $196,000 | 0.01% |
HOLLENCREST CAPITAL MANAGEMENT | 21,571 | $55,000 | 0.01% |
Walleye Capital LLC | 16,022 | $41,000 | 0.01% |